UPDATE: Oppenheimer Raises Amdocs' PT

According to a research report published this morning, Oppenheimer has increased Amdocs' DOX PT from $34 to $36. In the report, Oppenheimer said, "DOX beat Street EPS and came in just shy of consensus revenue. With the exception of a slower than expected recovery of AT&T spending, DOX sees solid demand, particularly in Europe and developing regions. The AT&T slowdown should prove transitory, and two emerging market clients could become top ten customers this year. DOX purchased $117M in shares and announced a $0.13 quarterly dividend. Management believes it can distribute ~50% of its annual free cash flow via dividends and buybacks." Oppenheimer maintains its Outperform rating on Amdocs, which closed yesterday at $32.18.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!